Daniel Köhler

13PUBLICATIONS
18CO-AUTHORS
Radiation therapyPharmaceutical delivery technologiesPharmacogenomicsInstruments and techniquesOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 13, 2025
Age-Related Outcomes of [177Lu]Lu-PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Retrospective Analysis.

Nikolaus Schweigert, Nadja Strewinsky, Daniel Köhler

|Aug 06, 2025
Overview of selected completed prospective studies on PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer.

Amir Karimzadeh, Wencke Lehnert, Daniel Koehler

|Jan 22, 2025
Overview of selected completed prospective studies on PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer.

Amir Karimzadeh, Wencke Lehnert, Daniel Koehler

|Jan 11, 2025
Robot-Assisted PSMA-Radioguided Salvage Surgery for Oligorecurrent Prostate Cancer Using the Novel SENSEI® Drop-in Gamma Probe: Correlation of Intraoperative Measurements to Preoperative Imaging and Final Histology.

Giovanni Mazzucato, Fabian Falkenbach, Marie-Lena Schmalhofer

|Mar 13, 2024
Tumor Response Evaluation Using iRECIST: Feasibility and Reliability of Manual Versus Software-Assisted Assessments.

Inka Ristow, Lennart Well, Nis Jesper Wiese

|Oct 28, 2023
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer.

Fabian Falkenbach, Francesca Ambrosini, Pierre Tennstedt

Pageof 3

Frequent Collaborators

4 joint publications

Markus Sauer

3 joint publications

Tobias Maurer

2 joint publications

Fabian Falkenbach

2 joint publications

Pierre Tennstedt